Alcon and OpenAI make acquisitions; Tezspire's latest Phase 3 win
Alcon acquires Neurotech: The Swiss eye specialist paid $550 million upfront to acquire Neurotech Pharmaceuticals and could make additional payments if certain milestones are met. Alcon gains hold of an FDA-approved ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.